Relmada Therapeutics
RLMD
RLMD
48 hedge funds and large institutions have $4.36M invested in Relmada Therapeutics in 2024 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 11 increasing their positions, 20 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
75% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 28
89% less capital invested
Capital invested by funds: $40.2M → $4.36M (-$35.9M)
Holders
48
Holding in Top 10
–
Calls
$340K
Puts
$131K
Top Buyers
| 1 | +$78K | |
| 2 | +$73.6K | |
| 3 | +$72.1K | |
| 4 |
RA
Rosalind Advisors
Toronto,
Ontario, Canada
|
+$52K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$46.2K |
Top Sellers
| 1 | -$2.19M | |
| 2 | -$1.82M | |
| 3 | -$1.59M | |
| 4 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$1.56M |
| 5 |
SC
Shay Capital
New York
|
-$569K |